Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Lincoln Pharmaceuticals Ltd.

  • NSE: LINCOLN

  • BSE: 531633

  • Q
  • V
  • T
  • Strong Performer, Getting Expensive
69.15/100

Quality Score

High Financial Strength
41.50/100

Valuation Score

Mid Valuation
74.52/100

Technical Score

Technically Bullish
Broker Average Rating

0.00

Broker Average Rating

MFI

74.04

MFI Overbought

50Day SMA Rs

215.99 Rs

Price above SMA 215.99

Quality score

69.15

High Financial Strength

30Day SMA Rs

233.59 Rs

Price above SMA 233.59

Broker Covering stock

0.00

None Broker Covering stock

Broker 6M Target upgrade

0.00

None Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

None Broker 6M Target downgrade

Momentum score

74.52

Technically Bullish

Price to Book Ratio

1.98

Below industry Median

Broker Reports in 1Yr

0.00

None Broker Reports in 1Yr

TTM PE Ratio

9.94

Below industry Median

Broker 6M Reco upgrade

0.00

None Broker 6M Reco upgrade

RSI

68.94

RSI is mid-range

Net Profit Qtr Cr

14.99 Cr

Above industry Median

Operating Revenues Qtr Cr

101.03 Cr

Above industry Median

MACD

8.14

MACD above Signal and Center

Valuation score

41.50

Mid Valuation

MACD Signal Line

7.30

MACD above Signal and Center

FII holding holding %

0.00 %

FII holding holding

Promoter holding holding %

32.36 %

No change in Promoter holding

MF holding holding %

0.00 %

MF holding holding

Broker 6M Reco downgrade

0.00

None Broker 6M Reco downgrade

100Day SMA Rs

188.28 Rs

Price above SMA 188.28

Institutions holding holding %

0.44 %

Institutions holding increased by 0.09%.

200Day SMA Rs

178.22 Rs

Price above SMA 178.22

NSE LINCOLN
260.25
  • 261.45 Close
  • 263.65 Open
  • 4.91 Lk Volume
Today Low/High
Low 256.60
High 272.00
52 Week Low/High
19-03-2020 85.05
18-09-2020 272.00

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Lincoln Pharmaceuticals Ltd. 260.25 9.93 520.5 1.15 14.99 0 101.03 6.81 1.98
Sun Pharmaceutical Industries Ltd. 523.35 491.26 125567.36 0.76 -2429.81 0 7585.25 -9.43 2.55
Divi's Laboratories Ltd. 3344.4 55.61 88777.09 0.47 492.06 0 1730.47 48.8 12.14
Dr. Reddy's Laboratories Ltd. 5333.35 46.73 88640.27 0.46 586.9 0 4426.5 14.72 5.68
Cipla Ltd. 806.25 39.44 65003.9 0.49 571.42 0 4346.16 8.95 4.04
Lupin Ltd. 1085.9 -105.29 49202.12 0.55 108.14 0 3527.86 -20.16 3.91
Torrent Pharmaceuticals Ltd. 2876.3 43.07 48678.5 1.11 321 0 2056 1.68 10.09
Aurobindo Pharma Ltd. 828.1 16.13 48518.37 0.51 792.68 0 5924.78 8.81 2.88